Skip to content

Nexus Enterprise Diagnostics

Active
Public limited companyfounded 2016active for 9 yearsKielsevest 14, 2018 Antwerpen, Belgium18 active companies are registered at this addressKBO/BCE: BE 0665.898.070
Summary

The computed 12-month bankruptcy probability of Nexus Enterprise Diagnostics is 7.5% (elevated). The 2024 annual accounts show negative equity (-€821,932) and a net result of -€77,233. Equity is shrinking by about 27% per year across the filed financial years. Its solvency ranks better than 5% of 8,972 sector peers (NACE 46, financial year 2024). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€55,763total assets 2024
Staff
0.5 FTE
Equity
-€821,932
Loss
-€77,233
Turnover not published (abbreviated or micro format)
Financial health
32 Weak Checked score 2024
Bankruptcy probabilitywithin 12 months
7.5%
Structure
Accounts 82 days overdue2 of 6 deeds read
Why 32raises risk1 financial year not filed after the legal deadline; latest accounts 69 days late; 3 of the last 3 lateLoss of €77,233, the second in a row (financial year 2024)Figures for financial year 2024 (filed 08-10-2025)Liquidity: current ratio 0.06, cash €0Show the evidence

Checked score

Score 2024
32 / 100
Weak
Probability in this band: 4.2% to 15.0%
Financially better than 10% of its sector peers (NACE 46, micro)
Financial strength · tick = 2023
Weak
Solvency 0=
equity -1474.0% of total assets
Liquidity 0=
short-term debt 1539.8% · cash 0.0%
Profitability 0=
return on assets -138.5%
Bankruptcy probability, 12 months
7.5% Elevated
0%0.5%1.5%4%10%≥ 25%

About 8 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,877 companies, NACE 46, micro)
Last 24 months 11-2024: 5.3% 12-2024: 5.2%▼ -0.1 percentage points vs 11-2024 01-2025: 5.6%▲ +0.4 percentage points vs 12-2024 02-2025: 5.6%● unchanged vs 01-2025 03-2025: 5.4%▼ -0.2 percentage points vs 02-2025 04-2025: 5.4%● unchanged vs 03-2025 05-2025: 5.3%▼ -0.1 percentage points vs 04-2025 06-2025: 5.1%▼ -0.2 percentage points vs 05-2025 07-2025: 5.0%▼ -0.1 percentage points vs 06-2025lowest value 08-2025: 5.8%▲ +0.8 percentage points vs 07-2025 09-2025: 6.0%▲ +0.2 percentage points vs 08-2025 10-2025: 7.8%▲ +1.8 percentage points vs 09-2025highest value 11-2025: 6.2%▼ -1.6 percentage points vs 10-2025 12-2025: 6.2%● unchanged vs 11-2025 01-2026: 6.2%● unchanged vs 12-2025 02-2026: 6.2%● unchanged vs 01-2026 03-2026: 6.1%▼ -0.1 percentage points vs 02-2026 04-2026: 6.0%▼ -0.1 percentage points vs 03-2026 05-2026: 6.0%● unchanged vs 04-2026 06-2026: 5.9%▼ -0.1 percentage points vs 05-2026 07-2026: 5.8%▼ -0.1 percentage points vs 06-2026 08-2026: 6.4%▲ +0.6 percentage points vs 07-2026 09-2026: 6.4%● unchanged vs 08-2026 10-2026: 7.5%▲ +1.1 percentage points vs 09-2026
No credit on open account
Liquidity insufficient (current ratio 0.06, compared with 0.14 in 2023, below 1; cash: 0% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 6% on solvency, 1% on liquidity, 6% on profitability and 26% on growth.

The bankruptcy probability was computed on 20-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
raises riskneutral
raises risk · 1 financial year not filed after the legal deadline; latest accounts 69 days late; 3 of the last 3 late
NBB · filings
raises risk · Loss of €77,233, the second in a row (financial year 2024)
NBB · annual accounts
raises risk · Figures for financial year 2024 (filed 08-10-2025)
NBB · annual accounts
raises risk · Liquidity: current ratio 0.06, cash €0
NBB · annual accounts
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024
Equity per financial year
18192021222324
2018 to 2024 · latest year -€821,932
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 82 days later.
NBB · 8 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline21-10-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 08-10-2025, 69 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 8 filings
Deviation from the deadline
2025
not filed
2024
69 days late
2023
78 days late
2022
70 days late
2021
144 days late
2020
90 days late
2019
60 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 85 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · abbreviated…
  2. Annual accounts filedfinancial year 2023 · micro…
  3. MiscellaneousPower of attorney

Key points

  • Risk: Negative equityfinancial year 2024: debts exceed assets -€821,932 View
  • Risk: 7 loss-making years in a rowloss financial year 2024 -€77,233 View
  • Caution: Among the weakest 5% on solvencysector median 44.0% · 8,972 companies -1474.0% View
  • Caution: Accounts not fileddeadline was 31-07-2026 82 days late View
  • Positive: Result rose in 2024from -€138,123 to -€77,233 ▲ 44.1% View

By topic

Financials

Financial year
2024
Total assets
€55,763
Loss
-€77,233
Solvency
-1474.0%
Total assets▼ 54.4%
Net result
20182024
Go to Financials

Timeline

Events
11
Since
2018
  1. 08-04-2024Appointments: Nexus Enterprise Diagnostics Holding B.V. (bestuurder,gedelegeerd…
  2. 09-10-2023Annual accounts filed
  3. 31-12-2022Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
10-11-2016
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.